Regencell Bioscience Holdings Ltd (RGC) stock
RGCNasdaqMedicinal Chemicals & Botanical Products
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Jun 30, 2026Last filing: 20-F on Oct 7, 2026Score 5/30
$4.36−0.33 (-7.04%)
Close on Nov 19, 2026Market cap $2.16BP/E –Yield –
Regencell Bioscience price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Regencell Bioscience's price to book ratio was 201.0× on Nov 11, 2026, against 11.4× a year earlier. Over the last 3 years it ranged from 3.6× to 249.3×, with a median of 16.5×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 201.0× | +106.0 |
| 2025 | Apr 30, 2025 | 95.0× | +87.2 |
| 2024 | Dec 31, 2024 | 7.8× | −3.5 |
| 2023 | Dec 29, 2023 | 11.4× | −9.9 |
| 2022 | Dec 30, 2022 | 21.3× | – |
See a number that looks wrong?